FdaApplication

BLA 103353

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAmgen Inc.
application_typeBLA
approval_date1991-02-20

Products (4)

ProductActive ingredientStrengthDosage form
NEUPOGENFILGRASTIM480MCG/1.6MLInjection
NEUPOGENFILGRASTIM300MCG/0.5MLInjection
NEUPOGENFILGRASTIM300MCG/MLInjection
NEUPOGENFILGRASTIM480MCG/0.8MLInjection

4 products